Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The proteasome 26S non-ATPase subunit 2 pseudogene (PSMD2P1) is a genomic sequence that closely resembles the coding gene for proteasome 26S non-ATPase subunit 2 (PSMD2), a component of the 19S regulatory particle of the 26S proteasome complex involved in protein degradation. PSMD2P1 is considered a pseudogene and does not produce a functional protein. Pseudogenes may, in rare cases, play regulatory roles at the RNA level by acting as microRNA decoys or through other non-coding RNA functions, but there is no evidence that PSMD2P1 has such a function. This locus is not a relevant therapeutic target, nor is it implicated in drug mechanisms, clinical biomarkers, or current disease associations[2][7][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S non-ATPase subunit 2 pseudogene (PSMD2P1).